The number of diabetics has significantly increased over the past twenty years. There are over 200 million people worldwide who suffer from diabetes, leaving many dependent on medication.
Currently, several diabetic drugs are associated with pancreatic cancer, one of the deadliest forms of cancer. We are currently investigating the following diabetic drugs:
This group of diabetic drugs is being investigated based on scientific concerns that the drugs cause an increased risk of pancreatitis or precancerous changes to cells in the pancreas which may increase the risk of pancreatic cancer. Another scientific study found a higher rate of thyroid cancer associated with these types of medications.
A study involving the diabetic drug Avandia demonstrated a possible link between Avandia and heart and lung problems. In fact, some medical professionals have voiced their concern and recommended that the product be removed from the market. Another diabetic drug, Lantus, has also raised concerns about a link between Lantus and a greater risk of cancer.